203 related articles for article (PubMed ID: 15758808)
1. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.
van der Heijden AG; Verhaegh G; Jansen CF; Schalken JA; Witjes JA
J Urol; 2005 Apr; 173(4):1375-80. PubMed ID: 15758808
[TBL] [Abstract][Full Text] [Related]
2. The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro study.
Arentsen HC; Falke J; Høgset A; Oosterwijk E; Alfred Witjes J
Urol Oncol; 2014 Jan; 32(1):49.e1-6. PubMed ID: 24140247
[TBL] [Abstract][Full Text] [Related]
3. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines.
van der Heijden AG; Jansen CF; Verhaegh G; O'donnell MA; Schalken JA; Witjes JA
Eur Urol; 2004 Nov; 46(5):670-4. PubMed ID: 15474281
[TBL] [Abstract][Full Text] [Related]
4. Chemoablation in Urothelial Carcinoma: A Systematic Review and Future Perspectives.
Alsyouf M; Pierorazio P; Groegler J; Hu B
Urology; 2020 Oct; 144():28-37. PubMed ID: 32540302
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin.
Krause S; Förster Y; Kraemer K; Fuessel S; Kotzsch M; Schmidt U; Wirth MP; Meye A; Schwenzer B
J Urol; 2005 Jul; 174(1):328-31. PubMed ID: 15947684
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation.
Cameron RB; Hou D
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):496-504. PubMed ID: 23174177
[TBL] [Abstract][Full Text] [Related]
7. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
[TBL] [Abstract][Full Text] [Related]
8. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro.
Freund CT; Tong XW; Rowley D; Engehausen D; Frolov A; Kieback DG; Lerner SP
Urol Oncol; 2003; 21(3):197-205. PubMed ID: 12810206
[TBL] [Abstract][Full Text] [Related]
9. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
[TBL] [Abstract][Full Text] [Related]
11. [Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].
Asadauskiene J; Aleknavicius E; Zelviene TP; Jankevicius F
Medicina (Kaunas); 2006; 42(10):781-7. PubMed ID: 17090976
[TBL] [Abstract][Full Text] [Related]
12. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
13. Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study.
Rath-Wolfson L; Moskovitz B; Dekel Y; Kugel V; Koren R
Int J Exp Pathol; 2003 Jun; 84(3):145-52. PubMed ID: 12974944
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer.
Colombo R; Da Pozzo LF; Lev A; Freschi M; Gallus G; Rigatti P
J Urol; 1996 Apr; 155(4):1227-32. PubMed ID: 8632537
[TBL] [Abstract][Full Text] [Related]
15. Systemic chemotherapy of transitional cell carcinoma of the urothelium.
Brinkley WM; Torti FM
Semin Surg Oncol; 1997; 13(5):365-75. PubMed ID: 9259093
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
Speers AG; Lwaleed BA; Featherstone JM; Cooper AJ
J Urol; 2007 Nov; 178(5):2171-5. PubMed ID: 17870115
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
Halim A; Abotouk N
Asia Pac J Clin Oncol; 2013 Mar; 9(1):60-5. PubMed ID: 22897883
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
19. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
